Skip to main content

U.S. Department of Defense awarded $2.8 million to UNC Institute for Trauma Recover researchers led by Samuel McLean, MD, to test the safety and efficacy of BXCL501 – sublingual dexmedetomidine created by BioXcel Therapautics for treating acute stress reaction symptoms and preventing posttraumatic stress.

October 15, 2024

Welcome Dr. Kelsey, Johnson!

October 15, 2024
Dr. Johnson is a geriatric psychiatrist who specializes in treating mental health concerns and neurocognitive disorders in older adults. She works in inpatient , outpatient , and long term care settings. Her areas of interest include the behavioral and psychological symptoms of dementia , caregiver burnout , and resident education.

6 Ways to Help Children After a Hurricane with Dr. Nadia Charguia

October 14, 2024

Walk for Hope: Team UNC Psychiatry raises over $14,000 for Mental Illness Research

October 14, 2024
Each year, thousands of participants come together at the Angus Barn in Raleigh to walk or run a 5K route to show solidarity for family, friends and community members living with a mental illness. Team UNC Psychiatry was 136 people strong this year and raised over $14,000 for our research...

Mary Beth Prieur, Ph.D. was awarded the Carolyn and C. Richard Mattingly Leadership in Mental Health Care award at the North American Cystic Fibrosis Conference

October 8, 2024
The Carolyn and C. Richard Mattingly Leadership in Mental Health Care Award highlights the significance of mental health to the overall well-being of those living with cystic fibrosis and on the important work of researchers and care teams who address mental health as an integral part of specialized CF care.

Feasibility, acceptability, and depression outcomes of a randomized controlled trial of Mindful Self-Compassion for Teens (MSC-T) for adolescents with subsyndromal depression.

October 1, 2024
Mindful Self-Compassion for Teens, an 8 session program which focuses on cultivating self-compassion as a coping skill for teens, was determined to be feasible, acceptable, and efficacious in preventing the development of clinically significant depression in adolescents with some depressive symptoms.

Facilitated Peer Group Mentoring for Underrepresented Biomedical Researchers: Facilitators’ Experiences and Implications for Dissemination of a Curriculum

October 1, 2024
Peer group mentoring facilitated by senior faculty represents an effective approach. We explored motivations, benefits, and challenges for facilitators enrolled to deploy an intervention in the context of a randomized controlled trial that tested two peer group mentoring strategies for underrepresented early career researchers.

Early cognitive development and psychopathology in children at familial high risk for schizophrenia

October 1, 2024
We studied cognitive development and psychopathology in children 4 and 6 years old who where at familial risk for developing schizophrenia and found delayed cognitive development and high rates of symptoms such as anxiety and attention problems, earlier than has previously been described. This indicates that risk for schizophrenia is...

Research with women sexual assault survivors presenting for emergency care is safe: Results from a multi-site, prospective observational cohort study

October 1, 2024
A large cohort of 706 women sexual assault survivors presenting to emergency care were recruited nationwide and followed over one year post-assault. Our findings suggested that the vast majority of women rated their research experience as positive (95-97%), denied drawbacks (84-89%), and reported participating was worth it (93-95%), and these...

Analysis of Depression and Anxiety Scores Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Adults With Cystic Fibrosis.

October 1, 2024
This work examines whether there are changes in the self-report of anxiety and depression symptoms in adults with cystic fibrosis (CF) who started taking elexacaftor/tezacaftor/ivacaftor (E/T/I), a new medication that shows great promise in the treatment of CF. The study found that there were no changes in these symptoms in...